Lee Financial’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-10
Closed -$1.59K – 913
2023
Q3
$1.59K Hold
10
– – ﹤0.01% 732
2023
Q2
$1.42K Hold
10
– – ﹤0.01% 707
2023
Q1
$1.68K Buy
+10
New +$1.78K ﹤0.01% 705
2022
Q4
– Sell
-11
Closed -$2K – 980
2022
Q3
$2K Hold
11
– – ﹤0.01% 699
2022
Q2
$2K Hold
11
– – ﹤0.01% 726
2022
Q1
$2K Sell
11
-46
-81% -$8.74K ﹤0.01% 672
2021
Q4
$15K Buy
57
+46
+418% +$12.4K ﹤0.01% 421
2021
Q3
$3K Hold
11
– – ﹤0.01% 565
2021
Q2
$2K Buy
+11
New +$2.13K ﹤0.01% 608
2017
Q4
– Sell
-225
Closed -$9K – 497
2017
Q3
$9K Buy
+225
New +$9.43K ﹤0.01% 357

Other funds holding RGEN

Lee Financial's RGEN Position: Q4 2023 in Review

Lee Financial sold out of Repligen (RGEN) in Q4 2023, closing a stake of 10 shares — an estimated $1.59K sold.

Lee Financial first reported a position in RGEN in Q3 2017 and held it in 10 quarters. The position peaked at $15K in Q4 2021. 466 funds tracked by Wall St. Rank hold RGEN as of Q4 2023.

  • Lee Financial reported no remaining Repligen position as of Q4 2023 after selling out during the quarter.
  • Lee Financial sold 10 Repligen shares in Q4 2023, an estimated $1.59K.
  • Lee Financial first reported a position in Repligen in Q3 2017 and held it in 10 quarters.
  • Lee Financial's Repligen position peaked at $15K in Q4 2021.
  • 466 funds tracked by Wall St. Rank held Repligen as of Q4 2023.

Based on Lee Financial's 13F filing for Q4 2023, filed 8 Feb 2024.